EZH2 and neuroblastoma: In another study, the overexpression of EZH2 in neuroblastoma was found to be associated with poor patient prognosis, and PRC2 mediated the silencing of tumor suppressor genes like CASZ1 through epigenetic changes (Wang et al., 2012).